The Roche towers in Basel. The pharmaceutical group overtook electrical engineering group ABB to claim first place for patent applications in Switzerland.
Keystone / Georgios Kefalas
Swiss companies filed almost seven times as many patent applications per million inhabitants last year as companies in the United States. The medical technology sector led the field.
After a slight decline due to Covid in 2020, patent applications in Europe rose again last year, the European Patent Office (EPO) said in a statementExternal link on Tuesday.
The Munich-based body received a total of 188,600 patent applications in 2021, an increase of 4.5% year-on-year, setting a new record. It registered 8,442 patent applications from Switzerland, up 3.9%.
The US remains the country with the highest number of patent applications (46,553), while patent filings from Chinese companies “continued to climb steeply”, increasing by 24% last year (16,665), the EPO said.
Per million inhabitants, however, Switzerland remains way out in the lead with 969 patent applications, followed by Sweden (488), Denmark (454), the Netherlands (383) and Finland (380). The US had 140 applications per million inhabitants and the UK 82.
More
More
Switzerland ranks among world leaders for trademark and patent filings
This content was published on
A record number of international patents were filed last year despite the Covid-19 pandemic.
At the European level the digital communication and information technology sector filed the most applications (15,400, 9.4%), followed by medical technology (15,231, 8.8%) and computer technology (14,671, 9.7%).
In Switzerland the medical technology sector applied for the most patents. This was followed by the consumer goods, metrology, electronic devices and machines, pharmaceuticals, chemistry and biotechnology sectors.
Among Swiss companies, Basel-based pharmaceutical group Roche overtook electrical engineering group ABB in first place. The two tobacco companies Japan Tobacco and Philip Morris were followed by Nestlé and Swatch Group.
Popular Stories
More
Workplace Switzerland
Trump tariff shock: how Switzerland is positioning itself
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
‘Pressure will increase on Switzerland to invest more in defence’
This content was published on
Markus Mäder, Switzerland's state secretary for security policy, believes that more cooperation is needed in order to strengthen defence in Europe.
Just one in five Swiss attend a religious service at Easter
This content was published on
Only one in five people in Switzerland attend a religious service during the Easter period or give up meat or alcohol for at least one day of fasting. Around 25% of those polled see Easter primarily as a family holiday, according to the survey.
Major road disruptions continue after heavy snowfall in parts of Switzerland
This content was published on
The snowfall has ended in the southern Swiss canton of Valais, the cantonal emergency services said on Friday. Several roads, however, remain closed.
Swiss businessman gets prison term for asbestos deaths
This content was published on
Stephan Schmidheiny has been sentenced to 9 years and 6 months in prison by the Turin Court of Appeal in a case against the former Eternit executive over deaths linked to asbestos exposure in Italy.
This content was published on
Swiss imports and exports reached new heights in the first quarter, driven by the chemicals and pharmaceuticals sectors. Shipments to the US rose sharply.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Genome editing’s patent problem fuels concern for the future of food
This content was published on
Genome editing is touted as a solution to feeding a planet battered by climate change. But an outdated patent system could stifle its potential.
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
Legal victory for Lindt in German chocolate bunny case
This content was published on
The Federal Court of Justice delivered its verdict on Thursday in a battle between Lindt and German company Heilemann, which in 2018 also marketed a chocolate bunny in a gold foil wrap. Lindt claimed it had a trademark on the colour, acquired by use, and that Heilemann had infringed this trademark and should be prevented…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.